Peg IFN-α-2b Clinical Trials

2 actively recruiting trials

No change since May 2026

Top Sponsors

First Affiliated Hospital Xi'an Jiaotong University1
Beijing 302 Hospital1

Indications

Liver Disease2
Hepatitis B Virus (HBV)1
Hepatitis B1
Hepatitis B, Chronic (CHB)1
Chronic Hepatitis b1

Other2 trials

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.